1. A compound composed of polyglycol (PEG) for the prevention and / or treatment of squamous head and neck cell carcinoma, with an average molecular weight of 800 or more and a concentration of 30 mg / ml or more. Methods of prevention and / or treatment of hncc. 1. Characteristic 1: components used to prevent and / or treat squamous head and neck cell carcinoma (hncc) of an object, including polyethylene (PEG) with a concentration of 30 mg / ml or more,a. The average molecular weight of Peggy (m695) is about 800 megatons or more； Claim 31: constituted in accordance with any of the above requirements prepared in the form of an aqueous solution or an aqueous solution, such as a mouthwash,Latex, toothpaste (e.g., toothpaste),Cream, such as lipstick,Ointment, foam, paint, sponge, gel, gum, aerosol, pill, trocisco, syrup (such as viscous syrup),Elector (linctus)Suspension, film (e.g. diving film)Compression agent (e.g. oral compression agent)4. Capsule (such as liquid capsule)；Film, ovarian compression coating, oral supplement Claim 33: composition consistent with any one of the 1 to 31 claims, including a therapeutic agent. Claim 34: the component of claim 33, wherein the therapeutic agent is an anticancer agent selected from anti EGFR, anti vegger, anti-igfr-1r, MTR, platinum, taxano, folato and other substances.Composiciones que comprenden polietilenglicol (PEG) con un peso molecular medio ponderal de 800 o mayor y una concentración de 30 mg/ml o mayor, para usar en la prevención y/o tratamiento de carcinoma de células escamosas de cabeza y cuello (HNSCC). Métodos para prevenir y/o tratar HNSCC. Reivindicación 1: Una composición para usar en la prevención y/o tratamiento del carcinoma de células escamosas de cabeza y cuello (HNSCC) en un sujeto, la composición comprende polietilenglicol (PEG) a una concentración de 30 mg/ml o mayor, donde el PEG tiene un peso molecular medio ponderal (Mʷ) de aproximadamente 800 daltones o mayor. Reivindicación 31: La composición de a
